Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2010
04/28/2010EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi)
04/28/2010EP1481062B1 Expec-specific proteins, genes encoding them and uses thereof
04/28/2010EP1346036B1 Helper virus-free herpes virus amplicon particles and uses thereof
04/28/2010EP1259606B1 Compositions useful for regulating parkin gene activity
04/28/2010EP1246647B1 Non-immunosuppressant hiv tat
04/28/2010EP1062240B1 N-terminally modified glp-1 derivatives
04/28/2010EP1060191B1 Derivatives of glp-1 analogs
04/28/2010EP1056775B1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action
04/28/2010EP1005537B1 Nucleic acid molecules specific for bacterial antigens and uses thereof
04/28/2010CN1952145B Paddy disease-resistance gene OsDR6
04/28/2010CN1822856B HCV vaccines
04/28/2010CN1820020B SARS-coronavirus virus-like particles and methods of use
04/28/2010CN1813066B Novel beta-actin and rps21 promoters and uses thereof
04/28/2010CN1798762B Tuberculosis vaccine with improved efficacy
04/28/2010CN1796403B Polypeptide and bacterin for preventing and curing infection of polytype human being papilomavirus
04/28/2010CN1786028B Plant dehydration response element conjugated protein, its coding gene and application
04/28/2010CN1771327B Stress tolerance
04/28/2010CN1767848B Survivin-derived peptides and use thereof
04/28/2010CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same
04/28/2010CN1756559B Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant
04/28/2010CN1615359B Process for producing l-amino acid using escherichia
04/28/2010CN1596266B Specific binding agents of human angiopoietin-2
04/28/2010CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system
04/28/2010CN101698847A Rice OsMS5 gene and coded protein thereof
04/28/2010CN101698679A Method for producing orally-taken blood sugar reducing proteins from larvas of human insulin transgenic house flies
04/28/2010CN101698678A Silkworm antibacterial peptide, cDNA sequence thereof and application thereof
04/28/2010CN101698677A Protein relevant to plant height, coding gene and application thereof
04/28/2010CN101698676A Recombinant vibrio vulnificus iron uptake regulatory protein and preparation method thereof
04/28/2010CN101698675A Recombinant vibrio parahaemolyticus flagellin and preparation method thereof
04/28/2010CN101698674A Recombinant vibrio parahaemolyticus outer membrane protein and preparation method thereof
04/28/2010CN101698673A Prawn white spot syndrome virus VP37p polypeptide fragment and application thereof
04/28/2010CN101142614B Single channel image resampling system and method using anisotropic filtering
04/27/2010USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors
04/27/2010USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein
04/27/2010USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied
04/27/2010US7705221 Plants and seeds of corn variety CV237850
04/27/2010US7705216 Corn event PV-ZMIR13 (MON863) plants and compositions and methods for detection thereof
04/27/2010US7705215 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
04/27/2010US7705195 Screening method
04/27/2010US7705141 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease
04/27/2010US7705140 DNAs encoding TNF receptor family members
04/27/2010US7705139 Zinc finger proteins for DNA binding and gene regulation in plants
04/27/2010US7705134 immunoglobulins; fibronectins; drug screening
04/27/2010US7705133 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits
04/27/2010US7705129 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
04/27/2010US7705128 Comprises interleukin-1 zeta polypeptides (IL-1) for diagnosis, prevention and treatment of tumors, allergies and infectious diseases
04/27/2010US7705127 HDM2 Polypeptides
04/27/2010US7705126 Compositions for controlling hair growth
04/27/2010US7705125 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
04/27/2010US7705124 Leucine-based motif and clostridial neurotoxins
04/27/2010US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases
04/27/2010US7705121 Chimeric human T1R3 taste receptor polypeptides and compositions containing same
04/27/2010US7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/27/2010US7705117 EGFH2 genes and gene products
04/27/2010US7704987 Metal complex based on 1,10-phenanthroline binds to histidine of the N-terminal loop of the peptide in such a way that the N-terminal loop (amino acid residues 1-15) is blocked or destabilised to inhibit the binding copper, zinc and iron compounds -ones of magnesium /calcium; Alzheimer,s disease
04/27/2010US7704970 DNA vaccination for treatment of autoimmune disease
04/27/2010US7704969 Transfection complexes
04/27/2010US7704964 Methods and compounds for the targeting of protein to exosomes
04/27/2010US7704963 Administering as antitumor or anticarcinogenic agent; interference RNA
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704950 Methods of using soluble heterodimeric cytokine receptor
04/27/2010US7704949 Perioperative injection of a polypeptide preferential inhibitor of kallikrein, rather than aprotinin, for cardiopulmonary bypass surgery or coronary artery bypass grafting
04/27/2010US7704947 Methods and compositions for the treatment of gastrointestinal disorders
04/27/2010US7704945 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18
04/27/2010US7704943 Angiogenesis inhibitors; using transglutaminase; antitumor agents; anticancer agents
04/27/2010US7704736 Compositions for the derivation of germ cells from stem cells and methods of use thereof
04/27/2010US7704720 Propagating viral RNA sequences in host cells for use as tools in developing vaccines against viral infection; genetic vaccines; immunotherapy
04/27/2010US7704718 a polypeptide with mutation in at least one specific amino acid capable of potentiating C1-INH protection against complement activity; esterage enzyme inhibitor; gastrointestinal disorders
04/27/2010US7704713 Polypeptides having DNA polymerase activity
04/27/2010US7704711 Human protein kinases and uses therefor
04/27/2010US7704710 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents
04/27/2010US7704709 Recombinant cytokine protein for use in treatment of leukemia
04/27/2010US7704703 Identifying modulators of tumor suppressor protein activity for use in treatment and prevention of infection and cell proliferative disorders
04/27/2010US7704701 Diagnosis of prostate cancer with SPAS-1 cancer antigen
04/27/2010US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators
04/27/2010US7704697 Nucleotide sequences coding protein 2A1of legionella for us as tool in diagnosis, prevention and treatment of legionnaires disease
04/27/2010US7704689 Method for generating hypermutable plants
04/27/2010US7704685 In vivo production of a clostridial neurotoxin light chain peptide
04/27/2010US7704514 Vaccines
04/27/2010US7704513 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus
04/27/2010US7704512 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
04/27/2010US7704509 Producing an infectious, self-replicating, recombinant human parainfluenza viral particle for use in developing vaccine or preventative against respiratory tract infections
04/27/2010US7704507 Anticancer vaccine and diagnostic methods and reagents
04/27/2010US7704505 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody
04/27/2010US7704501 Antibodies binding to human ataxin-1-like polypeptide
04/27/2010US7704500 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders
04/27/2010US7704499 Antibody against fragments of apo-lipoprotein B; for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases
04/27/2010US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
04/27/2010US7704497 Molecules with extended half-lives, compositions and uses thereof
04/27/2010US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
04/27/2010US7704492 providing recombinant adeno-associated virus (AAV) virion which comprises an AAV vector, AAV vector comprising selected gene operably linked to control elements capable of directing in vivo transcription and translation of selected gene and introducing recombinant AAV virion into muscle cell or tissue
04/27/2010US7704490 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity
04/27/2010US7704319 Crystal structure of an angiotensin-converting enzyme (ACE) and uses thereof
04/27/2010CA2468479C Podophyllotoxins as antiproliferative agents
04/27/2010CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor
04/27/2010CA2400570C Heterologous expression of neisserial proteins
04/27/2010CA2374377C Potassium channel kcnq5
04/27/2010CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins
04/27/2010CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis
04/27/2010CA2323776C Cytokine receptor common gamma chain like